ACS Includes Cologuard in Prevention and Early Detection Guidelines
Updated ACS guidelines for colorectal cancer include recommended use of a noninvasive stool-based DNA screening test every 3 years.
Read MorePosted by Steve Halasey | Nov 18, 2014 | Cancer, Molecular Diagnostics |
Updated ACS guidelines for colorectal cancer include recommended use of a noninvasive stool-based DNA screening test every 3 years.
Read MorePosted by Judy O'Rourke | Oct 4, 2013 | Uncategorized |
A range of products to explore, from bioMerieux’s new clinical mass spec MALDI-TOF-based system to new genetic tests for cancer, to bins to keep everything in its place.
Read MorePosted by Judy O'Rourke | Jul 10, 2013 | Information Technology, Lab Equipment |
Get a sneek peek at some products that will be unveiled at the 2013 AACC Expo.
Read MorePosted by Judy O'Rourke | Jun 18, 2013 | Cancer, Miscellaneous |
DNA confirmation ensures accurate patient identification of cervical cancer test specimen.
Read MorePosted by Judy O'Rourke | May 3, 2013 | Accessories, Anatomic Pathology, Information Technology, Lab Automation |
The array of products ranges from mouse monoclonal antibodies to pathology information systems.
Read More